Third, the severity of fibrosis is related to the risk of HCC development, and Takahashi reported that the serum levels of type IV collagen and the activity of tissue inhibitors of metalloproteinase-1 (TIMP-1) were significantly reduced by oral zinc supplement therapy [15]. This evidence concerns the gene TIMP1 and hepatocellular carcinoma.